Membrane-type matrix metalloproteinase-1 (MT1-MMP) is down-regulated in estrogen-deficient rat osteoblast in vivo (Q28564549)

31 January 2017

title

Membrane-type matrix metalloproteinase-1 (MT1-MMP) is down-regulated in estrogen-deficient rat osteoblast in vivo (English)

1 reference

ORCID Public Data File 2021

31 January 2017

0 references

1 reference

E. Y. Liao

1 reference

31 January 2017

H. J. Liao

1 reference

31 January 2017

L. J. Guo

1 reference

31 January 2017

H. D. Zhou

1 reference

31 January 2017

X. P. Wu

1 reference

31 January 2017

R. C. Dai

1 reference

31 January 2017

X. H. Luo

1 reference

31 January 2017

publication date

1 January 2004

1 reference

Journal of Endocrinological Investigation

31 January 2017

published in

1 reference

31 January 2017

1 reference

31 January 2017

1 reference

31 January 2017

page(s)

1–5

1 reference

A matrix metalloproteinase expressed on the surface of invasive tumour cells

31 January 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF03350902

Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350902

Effects of 17beta-estradiol on the expression of membrane type 1 matrix metalloproteinase (MT1-MMP) and MMP-2 in human osteoblastic MG-63 cell cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350902

Tissue inhibitor of metalloproteinase-2 (TIMP-2) binds to the catalytic domain of the cell surface receptor, membrane type 1-matrix metalloproteinase 1 (MT1-MMP)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350902

TIMP-2 is required for efficient activation of proMMP-2 in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350902

The C-Terminal Domain of Tissue Inhibitor of Metalloproteinases-2 Is Required for Cell Binding but Not for Antimetalloproteinase Activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350902

Cell surface binding of TIMP-2 and pro-MMP-2/TIMP-2 complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350902

Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350902

Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix-degrading activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350902

Cell migration through extracellular matrix: membrane-type metalloproteinases make the way

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350902

Regulation of tumour necrosis factor-alpha processing by a metalloproteinase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350902

Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350902

Processing of tumour necrosis factor-α precursor by metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350902

Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinases 2.

21 January 2018

1 reference

12 December 2020

MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover

1 reference

12 December 2020

Skeletal effects of estrogen

1 reference

12 December 2020

Regulation of matrix metalloproteinase expression in tumor invasion.

1 reference

12 December 2020

Contribution of MT1-MMP and of human laminin-5 gamma2 chain degradation to mammary epithelial cell migration

1 reference

12 December 2020

Prognostic values of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression in bladder cancer

1 reference

12 December 2020

The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3.

1 reference

12 December 2020

Expression of metalloproteinases and tissue inhibitors of metalloproteinases in human osteoblast-like cells: differentiation is associated with repression of metalloproteinase biosynthesis

1 reference

12 December 2020

Intermittent administration of parathyroid hormone (1-34) stimulates matrix metalloproteinase-9 (MMP-9) expression in rat long bone

1 reference

12 December 2020

Dimensions Publication ID

Identifiers

DOI

10.1007/BF03350902

0 references

1032817958

0 references

1 reference